Share Name Share Symbol Market Type Share ISIN Share Description
Synergy Hlth. LSE:SYR London Ordinary Share GB0030757263 ORD 0.625P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2,325.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 408.8 43.6 56.9 40.9 1,395.06

Synergy Health Share Discussion Threads

Showing 526 to 548 of 550 messages
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
DateSubjectAuthorDiscuss
03/11/2015
22:17
Game over ! Official List Cancellation effective today.
analyst
11/6/2015
11:17
that was from 27 may? Chart is doing an adam & eve (peg & bowl) now
luckymouse
20/10/2014
15:09
does the shire/abbvie debacle indicate the same for steria/synergy?
mw8156
13/10/2014
13:58
TREWSA.....they are too busy following quality companies like RRL :-)
henryatkin
13/10/2014
09:21
The takeover that nobody noticed.............
trewsa
26/6/2014
11:51
htTp://www.crackingbio.com/index.php/newsletter/mailing/view/listid-0/mailingid-14/listype-1 In Europe we remain long Summit, Plethora and Genfit. Synergy has been a real disappointment, but certainly its product looks approvable and it is better than the competing compound for chronic constipation. The stock looks cheap and management has made little secret of its desire to sell.
mail2
30/5/2014
12:05
Synergy health is on average the best performer of the whole index in the month of JuneOn average synergy rises 10.6% in the usual dire month of June
tokyo sexwhale
15/10/2013
15:32
bit of interest today
alchemy30
24/7/2013
18:15
Here's hoping for good news tomorrow!
sparkymoc
08/6/2013
06:42
Made a few quid on this following traderdiary.co.uk
birdsedgeuk
07/6/2013
17:51
Good call ahead of fine interim results - all key metrics 15% ahead.
analyst
01/6/2013
22:41
Been tipped on traderdiary.co.uk for June. Ive bought in
birdsedgeuk
08/2/2013
19:12
Investors Chronicle says Sell Shares in cleaning and sterilisation specialist Synergy Health (SYR) have been notably strong performers lately, outpacing shares in similar companies by 20 per cent over the past quarter on the back of some promising deals in new markets. True, Synergy almost certainly has a solid future in its key markets, but, in the medium-term, the share rating has moved too far ahead of the group's growth prospects. Really brave punters might try 'short selling' the stock; meanwhile, shareholders might simply opt to sell. The trigger for the big share-price move was Synergy's decisive entry into the US hospitals market. The acquisition of SRI/Surgical Express, in particular, for $25m (£17m) got the City's admiration, especially because the price paid looked good for a business generating sales of more than $100m. However, it is not clear what effect the expansion will have on Synergy's underlying profit margins. These were more than 15 per cent in the first half of 2012-13, but there is a risk that the peculiarities of the US business could eat into them. This is because most US hospitals, unlike those in Synergy's core business with the NHS, have their own sterilising and cleansing facilities on-site. That means Synergy would be paid a fee as a service provider, rather than as a more lucrative full-facility operator. There is no doubt that the US market is far larger than anything Synergy has entered so far and the opportunities are there. However, the question hanging over the States-side project is whether investors have taken into account the amount of investment needed over the next few years to bring the service up to Synergy's standards. That could generate big one-off costs that may not be adequately priced in. As support services businesses go, Synergy is unusual because a lot of its capital is tied up in tangible assets. That's because often it has to fund and build hospital cleaning facilities itself for the contracts it wins. That means lots of upfront spending in order to grow sales, as each new contract can mean another round of construction. Analysts at broker CanaccordGenuity estimate that to achieve an adequate cashflow return on its capital of around 8 per cent, the company must invest between £15m and £30m annually to generate the required income. This inhibits shareholders' returns as the lead time between winning a contract and starting operations is between 18 months to two years. CanaccordGenuity estimates that the company will clock up capital spending of £75m over the next three years. Given the lag between spending and revenue-generation, sales growth will be deferred, making Synergy much more cyclical than is generally perceived. Synergy also has its share of immediate problems resulting from austerity in the European Union. This affects its Dutch business supplying hospital linen, in particular. Meanwhile, a spending squeeze in the NHS, while not affecting existing contracts due to the importance for patient care, could slow the pipeline of new work that Synergy could bid for. Share tip summary Trading on almost 17 times forecast underlying earnings, Synergy's shares are rated just above the UK average for the healthcare services sector at a time when significant parts of its operations face slowing growth in its established markets. Granted, expansion into the US seems like a good move given the size of the market, and European austerity will not last for ever. Yet the rating has moved to a level that is vulnerable to correction if the company fails to outperform the market's expectations. Given the consistently high capital spending Synergy must undertake, the possibility of disappointment is higher than average. Sell.
analyst
02/1/2013
11:15
Yes, because it's one of the most resilient and steady companies around, with this year's adjusted eps likely to come in around 68p and the small divi holding steady. It also has long periods where it is undervalued and no one writes on this BB. I've learned to see the value of SYR.....
don carter
28/12/2012
17:47
Is the current price justified?
analyst
07/7/2012
19:36
What The Brokers Say 08 June 2012 Singer Capital Markets upgrades Synergy Health from Fair Value to Buy and raises its target price from 887p to 939p. 12 June 2012 Investec reiterates its Buy recommendation for Synergy Health with a target price of 980p. Morgan Stanley retains its Overweight rating for Synergy Health with a target price of 1085p. 06 July 2012 Jefferies International retains its Buy rating for Synergy Health with a target price of 1150p. Sources: http://www.stockmarketwire.com/article/4384849/FLASH-Singer-Capital-Markets-upgrades-Synergy-Health-from-fair-value-to-buy-target-price-raised-from-887p-to-939p.html http://sharedealing.nandp.co.uk/quote/?epic=SYR P.S. Here's a couple of links about SCLP, one of the hottest stocks at the moment: http://www.euroinvestor.com/community/discussionthread.aspx?threadid=252803 http://www.euroinvestor.com/community/discussionthread.aspx?threadid=253089
northernlass
07/6/2012
15:29
Placing completed and 2 directors much involved. A very good sign, methinks.
don carter
07/6/2012
09:48
In current climate, these results are good, but next time it would be nice to see a substantial leap forward in growth as a result of these acquisitions. Mind you SYR is as reliable as ever in beating expectations in a dire market, and eps growth is about 13% last year - so let's keep perspective.
don carter
07/6/2012
07:04
rolling over time to fade as investors realise aquisition-led growth has to stop one day
hyper ai
08/5/2012
17:56
Break to downside.
analyst
07/2/2012
19:31
Chief Exec has sold more than half his holding for £5.7 million to help pay his tax bill!
analyst
07/2/2012
17:59
Come on SYR, time for a little run to 975p....
don carter
10/11/2011
08:15
Half-year report: in line - done well to do that despite global macro-economic difficulties.
don carter
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20161208 04:04:42